Pangrol (Pancreas Powder From Porcine)

The powder contains lipase, amylase and protease enzymes that act in the small intestine to hydrolyze dietary fats, carbohydrates and proteins. By providing these enzymes externally, it compensates for the lack of endogenous pancreatic secretions, restoring normal digestive processes and enhancing nutrient uptake.

The appropriate dose of Pangrol is individualized by the prescribing healthcare professional based on the patient’s age, weight, severity of enzyme deficiency, and dietary fat content. Dosage is typically expressed in lipase units per meal and adjusted according to clinical response and tolerance.

Limited clinical data are available for use in pregnancy and lactation. Pangrol should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss individual risk factors and monitor both mother and child closely.

To order Pangrol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Pangrol is comparable to other porcine‑derived enzyme preparations in its composition of lipase, amylase and protease. Differences may lie in enzyme potency, particle size, and formulation (e.g., enteric coating). Clinicians choose a product based on patient tolerance, dosing convenience, and specific clinical needs.

Store Pangrol at ambient temperature below 25 °C in its original container, protecting it from moisture, heat and direct sunlight. Ensure the packaging remains sealed until use to maintain enzyme activity. Do not store in a refrigerator or freezer unless specifically instructed by the supplier.

Pangrol is taken orally, usually mixed with a small amount of water or soft food and consumed at the start of each main meal and snack that contains fat. The exact method (mixing vs. swallowing) should follow the prescribing clinician’s instructions to ensure optimal enzyme activation.

The most serious risks include allergic reactions that can progress to anaphylaxis, exacerbation of pancreatitis, and severe abdominal pain. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, persistent severe pain, or any signs of a systemic allergic response.

Pangrol should not be used by individuals with a known hypersensitivity to porcine proteins or any of the product’s excipients. It is also contraindicated in patients with active pancreatitis until the condition is stabilized, and in those for whom enzyme replacement therapy is not indicated.